alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › emerging-drug

emerging-drug

3 studies tagged emerging-drug, dated 2011-10-01 to 2020-08-20. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs 2020-08-20
  2. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients 2016-10-06
  3. Current and emerging drug treatment options for Alzheimer's disease: a systematic review 2011-10-01

Studies

3 studies carry this tag.

Date range

2011 to 2020

Top journals

  • Expert opinion on emerging drugs 2
  • Drugs 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Anti-amyloid-β protein agents for the treatment of Alzheimer's disease: an update on emerging drugs

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Expert opinion on emerging drugs 2020-08-20 Treatments

    Currently available Alzheimer's disease (AD) therapeutics are only symptomatic, targeting cholinergic and glutamatergic neurotransmissions.

  2. Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Expert opinion on emerging drugs 2016-10-06 Treatments

    Currently available drugs against Alzheimer's disease (AD) target cholinergic and glutamatergic neurotransmissions without affecting the underlying disease process.

  3. Current and emerging drug treatment options for Alzheimer's disease: a systematic review

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Drugs 2011-10-01 Treatments

    Alzheimer's disease (AD) is a progressive and ultimately fatal condition that causes debilitating memory loss and extensive deterioration of cognitive and functional abilities.

All topic tags with their study counts